Johnson & Johnson may have left the gate than some digital surgery competitors but Ashley McEvoy, executive vice president, worldwide chairman, medical devices, says the company has the technology and the team to win the race.
In an interview with DeviceTalks Weekly Podcast, McEvoy said robotic and digital surgery systems currently on the market have only been adopted by a small percentage of providers, leaving the field open for new competitors like J&J.
“Surgery is a slow adoption business,” McEvoy said,
While offering “huge respect” for the first movers. McEvoy said J&J enjoys market leadership right now in surgery. Its size and reach will open doors for its three digital surgery systems – Velys, Monarch and Ottava.
“We’re going to have a differentiated value proposition doing so in a broad-based healthcare, J&J fashion, not just like a standalone med tech company,” she said.
McEvoy pointed to the team J&J as as…